Blaine Davis

Blaine Davis

Plus aucun poste en cours

Fortune : 284 674 $ au 30/06/2026

52 ans
Health Technology
Commercial Services
Consumer Services

Profil

Mr. Blaine T.
Davis
is a Chief Financial Officer at Cartesian Therapeutics, Inc. Mr. Davis was previously employed as a Chief Financial Officer by Selecta Biosciences, Inc., a Chief Financial Officer by Protara Therapeutics, Inc., a Vice President, Head-IR & Corporate Communications by Insmed, Inc., a President by Endo Ventures Unlimited Co., a SVP-Investor Relations & Corporate Communications by Endo International Ltd., a SVP-Corporate Affairs & Investor Relations Contact by Endo Health Solutions, Inc., a Director-Business Development by Bristol Myers Squibb Co., and a Vice President-Capital Markets by Thomcorp Holdings, Inc. He received his undergraduate degree from Middlebury College.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
0,09 %
14/04/2026 27 320 ( 0,09 % ) 284 674 $ 30/06/2026

Postes actifs de Blaine Davis

SociétésPosteDébut

Anciens postes connus de Blaine Davis

SociétésPosteFin
CARTESIAN THERAPEUTICS, INC. Directeur Financier/CFO 01/01/2024
PROTARA THERAPEUTICS, INC. Directeur Financier/CFO 15/07/2022
INSMED INCORPORATED Investor Relations Contact 01/01/2020
Public Communications Contact 01/12/2016
President 01/01/2015
Voir l'expérience en détail de Blaine Davis

Formation de Blaine Davis

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Blaine Davis
🔇